Phase I/II Study of Paclitaxel Plus CPT-11 in Pts. With 2nd Line Chemotherapy of Inoperable or Recurrent GC.

NCT00209612 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

40

Enrollment

OTHER

Sponsor class

Stopped due to strong side effect

Conditions

Gastric Cancer

Interventions

DRUG: Taxol
DRUG: Campt, Topotesin

Sponsor

Hokkaido Gastrointestinal Cancer Study Group

Collaborators

[object Object]